159 related articles for article (PubMed ID: 25220271)
21. Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years.
Bhandari B; Pal A; Maulik S; Chakraborti S
J Indian Med Assoc; 2012 Oct; 110(10):710-4. PubMed ID: 23738404
[TBL] [Abstract][Full Text] [Related]
22. Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis.
Wang GB; Xu ZJ; Liu HF; Zhou QG; Zhou ZM; Jia N
Chin Med J (Engl); 2012 Aug; 125(16):2890-4. PubMed ID: 22932086
[TBL] [Abstract][Full Text] [Related]
23. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
Gan HC; Hyoon K; Fong KY
Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
[TBL] [Abstract][Full Text] [Related]
25. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
26. Interstitial inflammation and long-term renal outcomes in lupus nephritis.
Alsuwaida AO
Lupus; 2013 Dec; 22(14):1446-54. PubMed ID: 24097970
[TBL] [Abstract][Full Text] [Related]
27. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
28. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system.
Yu F; Wu LH; Tan Y; Li LH; Wang CL; Wang WK; Qu Z; Chen MH; Gao JJ; Li ZY; Zheng X; Ao J; Zhu SN; Wang SX; Zhao MH; Zou WZ; Liu G
Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417
[TBL] [Abstract][Full Text] [Related]
29. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
[TBL] [Abstract][Full Text] [Related]
30. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
[TBL] [Abstract][Full Text] [Related]
31. Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy.
Dimitrijević J; Dukanović L; Kovacević Z; Bogdanović R; Maksić D; Hrvacević R; Aleksić A; Naumović R; Jovanović D; Brajusković G; Milosavljević I
Vojnosanit Pregl; 2002; 59(6 Suppl):21-31. PubMed ID: 12852143
[TBL] [Abstract][Full Text] [Related]
32. Renal biopsies in Puerto Rico patients with lupus nephritis.
Rodríguez VE; Rodríguez N; Mayor A; Negrón D
Bol Asoc Med P R; 2012; 104(2):50-2. PubMed ID: 23882974
[TBL] [Abstract][Full Text] [Related]
33. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
34. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.
Wakiguchi H; Takei S; Kubota T; Miyazono A; Kawano Y
Clin Rheumatol; 2017 Feb; 36(2):433-437. PubMed ID: 27900491
[TBL] [Abstract][Full Text] [Related]
35. Tubulointerstitial nephritis in systemic lupus erythematosus: innocent bystander or ominous presage.
Dhingra S; Qureshi R; Abdellatif A; Gaber LW; Truong LD
Histol Histopathol; 2014 May; 29(5):553-65. PubMed ID: 24288339
[TBL] [Abstract][Full Text] [Related]
36. Image-directed color Doppler ultrasonography of kidney in systemic lupus nephritis.
Ozbek SS; Büyükberber S; Tolunay O; Erden MI; Aytaç SK; Olmez U
J Clin Ultrasound; 1995 Jan; 23(1):17-20. PubMed ID: 7699088
[TBL] [Abstract][Full Text] [Related]
37. Low level of circulating basophil counts in biopsy-proven active lupus nephritis.
Liang P; Tang Y; Lin L; Zhong H; Yang H; Zeng Y; Lv J; Li X; Lu Y; Xu A
Clin Rheumatol; 2018 Feb; 37(2):459-465. PubMed ID: 28988406
[TBL] [Abstract][Full Text] [Related]
38. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
39. [Long-term outcome of paediatric lupus nephritis].
Casado Picón R; Lumbreras Fernández J; Muley Alonso R; Vara Martín J
An Pediatr (Barc); 2010 May; 72(5):317-23. PubMed ID: 20392678
[TBL] [Abstract][Full Text] [Related]
40. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
